Sudden Death in Chronic Lymphocytic Leukemia (CLL) Patients on Ibrutinib - Dr. Clare Sun ASH 2022 скачать в хорошем качестве

Sudden Death in Chronic Lymphocytic Leukemia (CLL) Patients on Ibrutinib - Dr. Clare Sun ASH 2022

A small but significant number of sudden deaths over the past decade among chronic lymphocytic leukemia (CLL) patients due to atrial fibrillation while taking ibrutinib was found by the National Institutes of Health (NIH). Dr. Clare Sun offers advice on how patients who need ibrutinib should be thoroughly tested for the potential for cardiac issues before starting treatment. Dr. Clare Sun, an Associate Research Physician at the National Heart, Lung, and Blood Institute (NHLBI), a part of the NIH, is one of the eight co-authors of the report presented in December 2022 at the American Society of Hematology (ASH) annual conference. Read the full article on CLL Society's website at: https://cllsociety.org/2023/01/ash-20... __________________________________________________________________________________________ CLL Society Website: https://cllsociety.org/ Facebook:   / cllsociety   Twitter:   / cllsociety   LinkedIn:   / cll-society